日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

更正:DNAJB1-PRKACA融合通过损害SIK信号传导和CRTC2/p300介导的转录重编程驱动纤维板层型肝癌

Gritti, Ilaria; Wan, Jinkai; Weeresekara, Vajira; Vaz, Joel M; Tarantino, Giuseppe; Bryde, Tenna Holgersen; Vijay, Vindhya; Kammula, Ashwin V; Kattel, Prabhat; Zhu, Songli; Vu, Phuong; Chan, Marina; Wu, Meng-Ju; Gordan, John D; Patra, Krushna C; Silveira, Vanessa S; Manguso, Robert T; Wein, Marc N; Ott, Christopher J; Qi, Jun; Liu, David; Sakamoto, Kei; Gujral, Taranjit S; Bardeesy, Nabeel

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

DNAJB1-PRKACA融合通过损害SIK信号传导和CRTC2/p300介导的转录重编程驱动纤维板层肝癌

Gritti Ilaria, Wan Jinkai, Weeresekara Vajira, Vaz Joel M, Tarantino Giuseppe, Bryde Tenna Holgersen, Vijay Vindhya, Kammula Ashwin V, Kattel Prabhat, Zhu Songli, Vu Phuong, Chan Marina, Wu Meng-Ju, Gordan John D, Patra Krushna C, Silveira Vanessa S, Manguso Robert T, Wein Marc N, Ott Christopher J, Qi Jun, Liu David, Sakamoto Kei, Gujral Taranjit S, Bardeesy Nabeel